ACHAccendra Health, Inc.Healthcare · Medical - Distributionas of 2026-09-16
Horizon

Issued 2026-09-16 at $1.07 · now $1.07 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ACH has typically landed between $0.73 and $1.36 — a range of −32.1% to +27.3% from the issuance price $1.07.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,002 overlapping 1 month windows · 2006-09-262026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($1.07) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where ACH has typically landed a month from the 2026-09-16 close of $1.07 — the range is history, not a prediction.

$0.7265worst · -32.1%$1.36best · +27.3%
  • now $1.07 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.04 (-2.7%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $0.9161$1.17
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $0.7265$1.36
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,002 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2026-07-16−74.8%−74.8%+0.0%
2026-07-15−69.7%−69.7%+4.1%
2026-07-17−69.2%−72.6%+0.0%
3 best
2019-08-06+142.6%+0.0%+142.6%
2020-06-26+127.7%+0.0%+127.7%
2020-07-02+125.7%−1.1%+131.0%

5,002 overlapping windows · 2006-09-262026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
65%
+2.9%
n=20
Feb
60%
−0.5%
n=20
Mar
50%
+1.1%
n=20
Apr
45%
−0.8%
n=20
May
55%
−0.7%
n=20
Jun
50%
+3.2%
n=20
Jul
60%
+5.5%
n=20
Aug
25%
−4.3%
n=20
Sep
50%
+1.5%
n=20
Oct
45%
−5.8%
n=20
Nov
50%
+1.1%
n=20
Dec
50%
−1.1%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$6$1↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

17 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-05-18Galloway Heath HofficerWithheld for tax1,822166,306Form 4
2026-05-15Pesicka Edward AdirectorWithheld for tax17,6921,072,785Form 4
2026-05-15Bernocchi Perry AofficerWithheld for tax7,908313,913Form 4
2026-05-15Leon Jonathan AofficerWithheld for tax1,770290,533Form 4
2026-05-15Galloway Heath HofficerWithheld for tax966168,128Form 4
2026-05-14Klemash Stephen WdirectorAward / grant31,19190,242Form 4
2026-05-14Beck Mark AdirectorAward / grant31,19171,259Form 4
2026-05-14Bingham Gwendolyn MdirectorAward / grant31,19180,603Form 4
2026-05-14Gardner-Smith KennethdirectorAward / grant31,19186,113Form 4
2026-05-14Kline Teresa L.directorAward / grant31,19185,316Form 4
2026-03-20Pesicka Edward AdirectorWithheld for tax58,9451,090,477Form 4
2026-03-20Bernocchi Perry AofficerWithheld for tax20,841321,821Form 4
2026-03-20Leon Jonathan AofficerWithheld for tax11,286292,303Form 4
2026-03-20Galloway Heath HofficerWithheld for tax9,347169,094Form 4
2026-03-09Galloway Heath HofficerAward / grant61,437178,441Form 4
2026-03-09Leon Jonathan AofficerAward / grant85,067303,589Form 4
2026-03-09Bernocchi Perry AofficerAward / grant108,696342,662Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.